Authors
Latest:
Current status in buccal drug deliveryThe adequate absorption and transport of drugs in the body is part of optimal therapy. Drug administration perorally is easy, common and traditional, but occasionally alternative routes are required.
Latest:
Handling difficult samples in bio-analytical chemical analysisThere are two ways in which 'difficult' samples are usually categorized: either by the problems posed by the physical nature of the post-vivo sample matrix containing the chemical entity to be analysed, or...
Latest:
PVA copolymer: the new coating agentThe use of PVA copolymer-based film can solve the problems associated with lack of film adhesion... to tablets containing large amounts of waxy excipient or a lubricant.
Latest:
Quality by Design for analytical methods for use with orally inhaled and nasal drug productsThe design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.
Latest:
Improving liposome integrity and easing bottlenecks to productionThe importance of liposomes as an effective drug delivery system is well accepted in the pharmaceutical industry, but their handling remains a challenge.
Latest:
Using Industry 4.0 to Optimize Oral Solid Dosage Form ManufacturingReal-time monitoring and the principles of quality by design were used to optimize an OSD coating process.
Latest:
Enhanced brain drug delivery and targetingThe blood–brain barrier (BBB) forms an interface between the circulating blood and the brain, and functions as a tremendously effective barrier for the delivery of potential neurotherapeutics into the brain parenchyma. Conversely, the BBB possesses various carrier-mediated transport systems for the uptake of small molecules, such as essential nutrients and vitamins. These transporters have become an attractive target for drug/prodrug design in an attempt to ferry drug molecules across the BBB. Central nervous system (CNS) drug delivery is often limited by poor brain penetration of the potential drug candidate. As a result of its unique barrier properties, the BBB poses a huge challenge for the delivery of potential neurotherapeutics into the brain parenchyma.1 It is estimated that only 2% of small-molecule drugs and ,0.1% of novel protein and peptide pharmaceuticals developed for CNS diseases reach therapeutic concentrations in the brain.2,3 Many of the pharmacologically active drugs tend to fail..
Latest:
The influence of concomitant use of alcoholic beverages on hypromellose matrix tabletsResearch shows that both drug prescription and alcohol consumption increase within the elderly population. It is, therefore, necessary to fully understand the impact of alcohol consumption on solid oral dosage forms, especially extended release formulations.
Latest:
Formulating Topical Products Containing Live Microorganisms as the Active IngredientCase studies compare efficacy testing of preservatives for topical formulations with probiotic actives.
Latest:
Verification Methods for 198 Common Raw Materials Using a Handheld Raman SpectrometerUsing handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.
Latest:
EC Reviews: An Executive Country Review on TurkeyIn the wake of economic growth, healthcare reforms, and large-scale industry investment, Turkish pharmaceutical companies are charting their own destiny.
Latest:
Compliance in an Outsource Manufacturing Model: What to Look ForThe authors provide detailed lists of important checkpoints to consider when selecting an outsourcing provider.
Latest:
Formulation effects on the thermomechanical properties and permeability of free films and coating filmsUnderstanding a formulation's variable effects on its properties, especially film permeability, is key to designing a robust formulation and reducing variation of a finished product.
Latest:
Process Considerations During API DevelopmentThis article looks at how to adopt a systematic and prospective approach in the API development process to achieve documented, controlled synthetic processes...
Latest:
Establishing Material Compatibility, Process Conditions, and Bubble Points of FiltersThe authors explain the factors that can cause a failure in a bubble-point integrity test and what to consider when a product-specific bubble point must be defined.
Latest:
Peer-Reviewed Technical Note: Quality by Design in Freeze-DryingCycle design and robustness testing using advanced process analytical technology.
Latest:
Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble DrugBy optimizing formulation and process varibles, pellets can be prepared that can release a poorly soluble drug for 12-24 h following zero-order kinetics.
Latest:
Quality by Design for analytical methods for use with orally inhaled and nasal drug productsThe design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.
Latest:
Narrowing the gap between clinical capsule formulations and commercial film-coated tabletsBased on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Latest:
A Case for Developing a Standards-Based Approach to Plug-and-Play EquipmentIndustry needs a standard to connect systems and equipment sooner rather than later.
Latest:
Inside IPEC: Excipient Pedigree as a Supply Chain ToolIt's time to maintain a thorough traceable excipient trail.
Latest:
Analysis of the Indian Pharmaceutical IndustryIndia's pharmaceutical industry, which is one of the country's major economic sectors, is poised to make signficant gains on the global market.
Latest:
LC–MS/MS method for the determination of Vitamin D3 in human plasmaAn LC–MS/MS method for the quantitative determination of vitamin D3 in human plasma has been developed and validated with positive atmospheric chemical ionization sources.
Latest:
LC–MS/MS method for the determination of Vitamin D3 in human plasmaAn LC–MS/MS method for the quantitative determination of vitamin D3 in human plasma has been developed and validated with positive atmospheric chemical ionization sources.
Latest:
Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle managementOrally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.
Latest:
Hot-melt extrusion: an emerging drug delivery technologyHot-melt extrusion offers many advantages compared with conventional solid dosage form manufacturing, and has consequently received considerable attention from both the pharmaceutical industry and academia as a novel drug delivery technology. The possibility of forming solid dispersions with improved bioavailability renders hot-melt extrusion an excellent alternative to other conventionally employed techniques.
Latest:
Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process ConsiderationsUSP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.
Latest:
Joining the parallel lines...some companies complained that what they received was not joint advice or combined advice but parallel advice, without coherence...
Latest:
Fast dissolving disintegrating tablets with isomaltDuring the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.
